Multiple parameters for the comprehensive evaluation of the susceptibility of Escherichia coli to the silver ion
暂无分享,去创建一个
[1] Andrew A. Marino,et al. Silver-nylon: a new antimicrobial agent , 1983, Antimicrobial Agents and Chemotherapy.
[2] EuropeanCommittee forAntimicrobial SusceptibilityTesting. EUCAST Definitive Document E.Def 1.2, May 2000: Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. , 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[3] D. Long. Silver nitrate therapy as an adjunct in the treatment of myelomeningocele. , 1972, Journal of neurosurgery.
[4] R. Ersek,et al. Cross-linked silver-impregnated skin for burn wound management. , 1988, The Journal of burn care & rehabilitation.
[5] S. Shah,et al. Silver sulphadiazine: a comprehensive in vitro reassessment. , 1993, Chemotherapy.
[6] S Person,et al. Silver-coated nylon fiber as an antibacterial agent , 1987, Antimicrobial Agents and Chemotherapy.
[7] C. L. Fox. Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns. , 1968, Archives of surgery.
[8] S. Modak,et al. Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa. , 1973, Biochemical pharmacology.
[9] R. Becker,et al. Treatment of orthopaedic infections with electrically generated silver ions. A preliminary report. , 1978, The Journal of bone and joint surgery. American volume.
[10] R O Becker,et al. Electrically Generated Silver Ions: Quantitative Effects on Bacterial and Mammalian Cells , 1976, Antimicrobial Agents and Chemotherapy.
[11] R. Becker,et al. Antifungal Properties of Electrically Generated Metallic Ions , 1976, Antimicrobial Agents and Chemotherapy.
[12] S. Handelman,et al. Inhibition and Killing of Oral Bacteria by Silver Ions Generated with Low Intensity Direct Current , 1978, Journal of dental research.
[13] O. Cars,et al. Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin , 1992, Antimicrobial Agents and Chemotherapy.
[14] R. Tauxe,et al. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. , 1991, Epidemiologic reviews.
[15] L. Goodman,et al. The Pharmacological Basis of Therapeutics , 1941 .
[16] N. Grier. Silver and its compounds , 1977 .
[17] A. Harden. Bacterial Metabolism , 1930, Nature.
[18] J. Trevors,et al. Bacterial interactions with silver , 2005, Biology of Metals.
[19] A. Tomasz,et al. Antibiotic tolerance among clinical isolates of bacteria , 1986, Antimicrobial Agents and Chemotherapy.
[20] J. Karlowsky,et al. Effect of pooled human cerebrospinal fluid on the postantibiotic effects of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli , 1992, Antimicrobial Agents and Chemotherapy.
[21] K. Gadre,et al. Treatment of allergic and vasomotor rhinitis by the local application of different concentrations of silver nitrate , 1992, The Journal of Laryngology & Otology.
[22] M. Laverdière,et al. A NEW TYPE OF PENICILLIN RESISTANCE OF STAPHYLOCOCCUS AUREUS , 1977, The Lancet.